Tissue Engineered Transcatheter Pulmonary Valved Stent Implantation: Current State and Future Prospect
department or school: Other UBC
department or school: Non UBC
data provider: DSpace
identifier citation: International Journal of Molecular Sciences 23 (2): 723 (2022)
contributor: St. Paul's Hospital (Vancouver, B.C.). Centre for Heart Valve Innovation
creator: Zhang, Xiling
creator: Puehler, Thomas
creator: Seiler, Jette
creator: Gorb, Stanislav N.
creator: Sathananthan, Janarthanan
creator: Sellers, Stephanie
creator: Haneya, Assad
creator: Hansen, Jan-Hinnerk
creator: Uebing, Anselm
creator: Müller, Oliver J.
creator: Frank, Derk
creator: Lutter, Georg
issued: 2022-02-18T17:34:00Z
issued: 2022-01-10
description: Patients with the complex congenital heart disease (CHD) are usually associated with right ventricular outflow tract dysfunction and typically require multiple surgical interventions during their lives to relieve the right ventricular outflow tract abnormality. Transcatheter pulmonary valve replacement was used as a non-surgical, less invasive alternative treatment for right ventricular outflow tract dysfunction and has been rapidly developing over the past years. Despite the current favorable results of transcatheter pulmonary valve replacement, many patients eligible for pulmonary valve replacement are still not candidates for transcatheter pulmonary valve replacement. Therefore, one of the significant future challenges is to expand transcatheter pulmonary valve replacement to a broader patient population. This review describes the limitations and problems of existing techniques and focuses on decellularized tissue engineering for pulmonary valve stenting.
aggregated CHO: https://circle.library.ubc.ca/rest/handle/2429/80856
note: Citation: Zhang, X.; Puehler, T.;Seiler, J.; Gorb, S.N.; Sathananthan, J.;Sellers, S.; Haneya, A.; Hansen, J.-H.;Uebing, A.; Müller, O.J.; et al. TissueEngineered Transcatheter PulmonaryValved Stent Implantation: CurrentState and Future Prospect. Int. J. Mol.Sci. 2022, 23, 723. https://doi.org/10.3390/ijms23020723Academic Editors: Barbara Zavan,Stefano Sivolella and Alfredo RoncaReceived: 17 December 2021Accepted: 5 January 2022Published: 10 January 2022Publisher’s Note: MDPI stays neutralwith regard to jurisdictional claims inpublished maps and institutional affil-iations.Copyright: © 2022 by the authors.Licensee MDPI, Basel, Switzerland.This article is an open access articledistributed under the terms andconditions of the Creative CommonsAttribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). International Journal of Molecular SciencesReviewTissue Engineered Transcatheter Pulmonary Valved StentImplantation: Current State and Future ProspectXiling Zhang 1,2,†, Thomas Puehler 1,2,† , Jette Seiler 1,2, Stanislav N. Gorb 3 , Janarthanan Sathananthan 4,Stephanie Sellers 4, Assad Haneya 1, Jan-Hinnerk Hansen 5, Anselm Uebing 2,5, Oliver J. Müller 2,6 ,Derk Frank 2,6 and Georg Lutter 1,2,*1 Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein (UKSH), D-24105 Kiel,Germany; zhang_xiling@outlook.com (Z.X.); thomas.puehler@uksh.de (T.P.); jette.seiler@uksh.de (J.S.);assad.haneya@uksh.de (A.H.)2 DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, D-20251 Hamburg,Germany; anselm.uebing@uksh.de (A.U.); oliver.mueller@uksh.de (O.J.M.); derk.frank@uksh.de (D.F.)3 Department of Functional Morphology and Biomechanics, Zoological Institute,Christian-Albrecht University of Kiel, D-24105 Kiel, Germany; sgorb@zoologie.uni-kiel.de4 Department of Centre for Heart Valve Innovation, St Paul’s Hospital, University of British Columbia,Vancouver, BC V5K 0A1, Canada; jsathananthan@providencehealth.bc.ca (J.S.);SSellers…
has type: Article
is shown at: 10.14288/1.0406618
language: eng
peer review status: Reviewed
provider: Vancouver : University of British Columbia Library
publisher: Multidisciplinary Digital Publishing Institute
publisher DOI: 10.3390/ijms23020723
rights: CC BY 4.0
rights URI: https://creativecommons.org/licenses/by/4.0/
scholar level: Faculty
scholar level: Researcher
scholar level: Other
subject: tissue engineering
subject: heart valve replacement
subject: pulmonary
subject: transcatheter
subject: percutaneous
subject: biodegradable
subject: nitinol
subject: stents
subject: congenital heart disease
subject: decellularization
subject: recellularization
type: Text
identifier URI: http://hdl.handle.net/2429/80856